COMMUNIQUÉS West-GlobeNewswire
      -   
  
Sanofi : Résultats positifs de phase III pour Dupixent® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère inadéquatement contrôlée de l'adolescent
16/05/2018 -   
  
INNATE PHARMA : First quarter 2018 report
16/05/2018 -   
  
INNATE PHARMA : Information financière du premier trimestre 2018
16/05/2018 -   
  
Idorsia initiates MODIFY, a Phase 3 registration study to assess lucerastat as a potential new treatment option for patients with Fabry disease
16/05/2018 -   
  
Novartis announces changes to the Executive Committee
16/05/2018 -   
  
Targovax to present at upcoming investor and industry conferences
16/05/2018 -   
  
Assure Holdings Corp. Announces Appointment of New Auditor, New Executive Chairman and Interim Chief Executive Officer, New Role for Founder Preston Parsons, and Results of Forensic Audit
16/05/2018 -   
  
REVA Announces First Implants of the Fantom Bioresorbable Scaffold in Turkey
16/05/2018 -   
  
Pacific Health Care Organization, Inc. Reports First Quarter 2018 Results
15/05/2018 -   
  
Veritas Pharma Has Retained Cannabis Branding Firm for Design of Label and Packaging
15/05/2018 -   
  
Synergy CHC Corp. Announces First Quarter 2018 Results
15/05/2018 -   
  
Performance and Restricted Share Unit Plan Approved by IntelGenx Technologies Corp. Shareholders
15/05/2018 -   
  
Solid Biosciences Announces Upcoming Preclinical Data Presentations
15/05/2018 -   
  
Cerner and Uniform Data System for Medical Rehabilitation Create Standardized Integration
15/05/2018 -   
  
Molecular Templates to Present at the UBS Global Healthcare Conference
15/05/2018 -   
  
Precision Optics Corporation, Inc. Announces Operating Results for the Third Quarter and Nine Months of Fiscal Year 2018
15/05/2018 -   
  
AIT Therapeutics to Present Data from Its Inhaled Nitric Oxide Study in Patients Infected with Mycobacterium Abscessus Complex at the 2018 American Thoracic Society Conference
15/05/2018 -   
  
Milestone Scientific Provides Business Update for the First Quarter of 2018
15/05/2018 -   
  
POCML 4 Inc. Agrees to Qualifying Transaction With MediPharm Labs Inc.
15/05/2018 
Pages